Ibogaine News · Monday, September 21, 2026
Presley Gerber's death under investigation, ibogaine treatment noted
Gerber's recent ibogaine treatment and mental health struggles draw attention amid investigation.
Presley Gerber's death under investigation
The death of Presley Gerber, son of Cindy Crawford and Rande Gerber, is currently under investigation by the Santa Monica Police Department. According to the Los Angeles County Medical Examiner, an examination was scheduled for September 21, following Gerber's death at a rehabilitation facility on September 20. The cause of death has not been disclosed, and authorities have not indicated whether an overdose, accident, or foul play is suspected.
Recent ibogaine treatment
In the months leading up to his death, Gerber had been open about his struggles with addiction and mental health. In March, he shared on Instagram his experience preparing for an "ibogaine flood dose," a treatment he described as transformative. Ibogaine, a psychoactive substance derived from the Tabernanthe iboga shrub, is studied for its potential in treating addiction but is not approved for medical use in the U.S.
Family and public response
Gerber's family has requested privacy during this difficult time. His mother, Cindy Crawford, and sister, Kaia Gerber, publicly supported him in his efforts to address his mental health challenges. Kaia, in a Vogue interview, highlighted the impact of Presley's struggles on the family, praising his openness about his experiences.
Why it matters
The investigation into Presley Gerber's death and his recent ibogaine treatment underscore ongoing discussions about mental health and addiction treatment options. Ibogaine's unapproved status in the U.S. raises questions about alternative therapies for addiction and mental health issues.
Presley Gerber's journey through addiction and mental health challenges has brought attention to the complexities of treatment and the importance of family support.
Sources
Reporting based on complex.com. Read the original in the Sources section above.
Get the newsletter
Ibogaine news, in your inbox.
Occasional dispatches. No spam.